Familial dysalbuminemic hyperthyroxinemia coexisting with a Grave's disease: a Belgian case report
Fleur Wolff,Françoise Fery,Julie Désir,Romy Gadisseur,Etienne Cavalier,Frédéric Cotton
DOI: https://doi.org/10.1515/cclm-2024-0204
2024-04-03
Clinical Chemistry and Laboratory Medicine (CCLM)
Abstract:Research ethics: The local Institutional Review Board deemed the study exempt from review. Informed consent: Informed consent was obtained from all individuals included in this study, or their legal guardians or wards. Author contributions: Wolff Fleur wrote the draft. Fery Françoise and Désir Julie gave all the clinical data (case description and genetics results). Gadisseur Romy, Cavalier Etienne and Cotton Frédéric reviewed the letter to editor. The authors have accepted responsibility for the entire content of this manuscript and approved its submission. Competing interests: The authors state no conflict of interest. Research funding: None declared. Data availability: Not applicable. 1. Mimoto, MS, Refetoff, S. Clinical recognition and evaluation of patients with inherited serum thyroid hormone-binding protein mutations. J Endocrinol Invest 2020;43:31–41. https://doi.org/10.1007/s40618-019-01084-9. Search in Google Scholar PubMed PubMed Central 2. Berger, HR, Creech, MK, Hannoush, Z, Watanabe, Y, Kargi, A, Weiss, RE. A novel mutation causing complete thyroid binding globulin deficiency (TBG-CD MIA) in a male with coexisting Graves disease. AACE Clin Case Rep 2017;3:e134–9. https://doi.org/10.4158/ep161421.cr. Search in Google Scholar 3. Pappa, T, Ferrara, AM, Refetoff, S. Inherited defects of thyroxine-binding proteins. Best Pract Res Clin Endocrinol Metabol 2015;29:735–47. https://doi.org/10.1016/j.beem.2015.09.002. Search in Google Scholar PubMed PubMed Central 4. Li, Y, Chi, Y, Chai, X, Liu, H, Li, N, Lian, X. Familial dysalbuminemic hyperthyroxinemia combined with Graves' disease: a rare case report. BMC Endocr Disord 2023;23:226. https://doi.org/10.1186/s12902-023-01481-5. Search in Google Scholar PubMed PubMed Central 5. Khoo, S, Lyons, G, Solomon, A, Oddy, S, Halsall, D, Chatterjee, K, et al.. Familial dysalbuminemic hyperthyroxinemia confounding management of coexistent autoimmune thyroid disease. Diabetes Metab Case Rep 2020;2020:1–5. https://doi.org/10.1530/edm-19-0161. Search in Google Scholar PubMed PubMed Central 6. Kragh-Hansen, U, Galliano, M, Minchiotti, L. Clinical, genetic, and protein structural aspects of familial dysalbuminemic hyperthyroxinemia and hypertriiodothyroninemia. Front Endocrinol (Lausanne) 2017;8:297. https://doi.org/10.3389/fendo.2017.00297. Search in Google Scholar PubMed PubMed Central 7. Külz, M, Fellner, S, Rocktäschel, J, Ceglarek, U, Willenberg, A, Kratzsch, J. Dubiously increased FT4 and FT3 levels in clinically euthyroid patients: clinical finding or analytical pitfall? Clin Chem Lab Med 2022;60:877–85. https://doi.org/10.1515/cclm-2021-1211. Search in Google Scholar PubMed 8. Dieu, X, Bouzamondo, N, Briet, C, Illouz, F, Moal, V, Boux de Casson, F, et al.. Familial dysalbuminemic hyperthyroxinemia: an underdiagnosed entity. J Clin Med 2020;9:2105. https://doi.org/10.3390/jcm9072105. Search in Google Scholar PubMed PubMed Central 9. Cartwright, D, O'Shea, P, Rajanayagam, O, Agostini, M, Barker, P, Moran, C, et al.. Familial dysalbuminemic hyperthyroxinemia: a persistent diagnostic challenge. Clin Chem 2009;55:1044–6. https://doi.org/10.1373/clinchem.2008.120303. Search in Google Scholar PubMed 10. Westbye, AB, Aas, FE, Dahl, SR, Zykova, SN, Kelp, O, Dahll, LK, et al.. Large method differences for free thyroid hormone assays in the hyperthyroid range can affect assessment of hyperthyroid status: comparison of Abbott Alinity to Roche Cobas, Siemens Centaur -Abstract Truncated-
medical laboratory technology